And before you say it, yes I'm talking down GERN on the internet because that will protect my INCY position!
Seriously though, there is nothing controversial in what jq and I are saying. The data are written in the abstract and the response criteria are clear. You'll note that in the Sanofi JAK inhibitor abstract from that group, they note the spleen responses.
And seriously your hematologist should know about Jakafi's survival data. That ain't no joke.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.